SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-039119
Filing Date
2022-10-31
Accepted
2022-10-31 16:30:32
Documents
14
Period of Report
2022-10-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10043359_8k.htm   iXBRL 8-K 28146
2 EXHIBIT 99.1 brhc10043359_ex99-1.htm EX-99.1 14033
6 image0.jpg GRAPHIC 6839
  Complete submission text file 0001140361-22-039119.txt   191366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20221031.xsd EX-101.SCH 3881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20221031_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20221031_pre.xml EX-101.PRE 16055
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043359_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 221346407
SIC: 2836 Biological Products, (No Diagnostic Substances)